IRCT201210018698N1已完成未知
Effect of high dose allopurinol on cardiac biomarkers (CTnT, CKMB) in patients undergoing elective percutaneous coronary intervention
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •patients who are candidates for elective PCI.
- •Exclusion criteria: patients who are candidates for CABG or Primary PCI; Glomerular filtration rate less than 60 ml / min or serum creatinine more than 3 mg / dl; history of gout; taking allopurinol; severe liver disease; concomitant use of azathioprine, 6 - mercaptopurine or warfarin.
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease (ALL-HEART)Ischaemic Heart Disease (IHD), angina or myocardial infarctionMedDRA version: 16.0Level: LLTClassification code 10023024Term: Ischaemic heart diseaseSystem Organ Class: 100000004849EUCTR2013-003559-39-GBThe University of Dundee5,215
招募中
3 期
The Effect of Allopurinol on Percutaneous Coronary Intervention Outcomes in ST-segment Elevation Myocardial Infarction PatientsPrecancerous Coronary Intervention Outcome.ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20181228042155N1Esfahan University of Medical Sciences80
已完成
3 期
Effect of Allopurinol in treatment of patients with Non ST-segment elevation myocardial infarctioAcute myocardial infarction without ST segment elevation.Subsequent ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarctionIRCT20191223045866N1Esfahan University of Medical Sciences80
已完成
2 期
Evaluation of the effect of Allopurinol in reducing heart damage in acute ischemic heart patientsIRCT20111206008307N36Tabriz University of Medical Sciences100
已完成
不适用
Allopurinol and cardiovascular outcomes in patients with ischaemic heart diseaseISRCTN32017426The University of Dundee (UK)5,937